These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 992027)

  • 1. Characterization of a mannose-containing glycoasparagine isolated from urine of a patient with aspartylglycosylaminuria (AGU).
    Akasaki M; Sugahara K; Funakoshi I; Aula P; Yamashina I
    FEBS Lett; 1976 Oct; 69(1):191-4. PubMed ID: 992027
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of two glycoasparagines isolated from the urine of patients with aspartylglycosylaminuria (AGU).
    Sugahara K; Funakoshi S; Funakoshi I; Aula P; Yamashina I
    J Biochem; 1975 Oct; 78(4):673-8. PubMed ID: 1213985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartylglycosaminuria in an Italian family: clinical and biochemical characteristics.
    Gehler J; Sewell AC; Becker C; Spranger J; Hartmann J
    J Inherit Metab Dis; 1981; 4(4):229-30. PubMed ID: 6796777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated ion-exchange chromatography in the detection of aspartylglucosaminuria.
    Marnela KM
    J Chromatogr; 1980 Jun; 182(3-4):409-13. PubMed ID: 7391183
    [No Abstract]   [Full Text] [Related]  

  • 5. N-Acetylglucosamine-asparagine levels in tissues of patients with aspartylglycosaminuria.
    Maury CP; Palo J
    Clin Chim Acta; 1980 Dec; 108(2):293-9. PubMed ID: 7449147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of glycoprotein-derived metabolites in neural and visceral tissue in aspartylglycosaminuria.
    Maury CP
    J Lab Clin Med; 1980 Nov; 96(5):838-44. PubMed ID: 7419967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartylglucosamine excretion in heterozygous carriers of aspartylglycosaminuria.
    Mononen TK
    Clin Chim Acta; 1989 Mar; 180(1):99-101. PubMed ID: 2743573
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the storage material of peripheral lymphocytes in aspartylglycosaminuria.
    Maury P; Palo J
    Clin Sci (Lond); 1980 Feb; 58(2):165-8. PubMed ID: 7357836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aspartylglycosaminuria by gas--liquid chromatography.
    Maury CP
    Clin Chem; 1981 Dec; 27(12):2058-60. PubMed ID: 7307258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of two glycoasparagines isolated from the urine of patients with aspartylglycosylaminuria (AGU).
    Sugahara K; Akasaki M; Funakoshi I; Aula P; Yamashina I
    J Biochem; 1977 Nov; 82(5):1499-501. PubMed ID: 591515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis and fetal pathology of aspartylglucosaminuria.
    Aula P; Rapola J; von Koskull H; Ammälä P
    Am J Med Genet; 1984 Oct; 19(2):359-67. PubMed ID: 6507482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-chromatographic detection of aspartylglycosaminuria.
    Mononen T; Parviainen M; Penttilä I; Mononen I
    Clin Chem; 1986 Mar; 32(3):501-2. PubMed ID: 3948393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of glycoasparagines from urine of a patient with aspartylglycosylaminuria (AGU).
    Sugahara K; Akasaki M; Funakoshi I; Aula P; Yamashina I
    FEBS Lett; 1977 Jun; 78(2):284-6. PubMed ID: 885252
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspartylglycosaminuria in Northern Norway in eight patients: clinical heterogeneity and variations with the diet.
    Borud O; Strömme JH; Lie SO; Torp KH
    J Inherit Metab Dis; 1978; 1(3):95-7. PubMed ID: 116085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes.
    Näntö-Salonen K; Halme T; Penttinen R; Langevelde FV; Vis RD; Alfthan G
    J Inherit Metab Dis; 1985; 8(4):212-8. PubMed ID: 3939546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of one neutral and two acidic glycoasparagines isolated from the urine of patients with aspartylglycosylaminuria (AGU).
    Sugahara K; Funakoshi S; Funakoshi I; Alla P; Yamashina I
    J Biochem; 1976 Aug; 80(2):195-201. PubMed ID: 187576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine in the urine of patients with aspartylglycosaminuria by gas-liquid chromatography.
    Maury P
    J Lab Clin Med; 1979 May; 93(5):718-23. PubMed ID: 429870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical delineation of aspartyl-glycosaminuria as observed in two members of an Italian family.
    Gehler J; Sewell AC; Becker C; Hartmann J; Spranger J
    Helv Paediatr Acta; 1981; 36(2):179-89. PubMed ID: 6788730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine in biological materials by gas chromatography-mass spectrometry.
    Maury P; Kärkkäinen J
    Clin Chim Acta; 1979 Jan; 91(1):75-9. PubMed ID: 761395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra heating of TLC plates detects two lysosomal storage diseases, aspartylglucosaminuria and fucosidosis, during routine urinary amino acid screening.
    Simell O; Sipilä I; Autio S
    Clin Chim Acta; 1983 Sep; 133(2):227-32. PubMed ID: 6627685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.